Pentafluorobenzenesulfonyl chloride (PFBS-Cl) is a highly reactive electrophilic reagent used in organic synthesis. Its synthesis typically involves the reaction of pentafluorobenzene with chlorosulfonic acid. PFBS-Cl is a powerful sulfonylating agent and finds applications in the preparation of various sulfonamides, sulfones, and other sulfur-containing compounds. Due to its high reactivity, PFBS-Cl is also used in the development of new functional materials and pharmaceuticals. Its reactivity and potential for generating novel molecules make it a subject of ongoing research in organic chemistry.'
pentafluorobenzenesulfonyl chloride: RN given from first source; RN not in Chemline 1/85 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 70026 |
| SCHEMBL ID | 521623 |
| MeSH ID | M0128612 |
| Synonym |
|---|
| pentafluorobenzenesulfonyl chloride |
| benzenesulfonyl chloride, pentafluoro- |
| STK503645 |
| nsc96998 |
| nsc-96998 |
| 832-53-1 |
| pentafluorobenzenesulfonyl chloride, 99% |
| 2,3,4,5,6-pentafluorobenzenesulfonyl chloride |
| P0934 |
| AKOS000128644 |
| unii-2p6fr9sy79 |
| 2p6fr9sy79 , |
| einecs 212-620-0 |
| pentafluorobenzenesulphonyl chloride |
| nsc 96998 |
| FT-0633013 |
| BP-21449 |
| SCHEMBL521623 |
| DTXSID50232213 |
| pentafluorobenzene-sulfonyl chloride |
| c6f5so2cl |
| 2,3,4,5,6-pentafluorobenzene-1-sulfonyl chloride |
| c6clf5o2s |
| benzene,1-chlorosulphonyl-2,3,4,5,6-pentafluoro- |
| pentafluorophenylsulfonyl chloride |
| 2,3,4,5,6-pentafluoro-benzenesulfonyl chloride |
| pentafluorobenzene-1-sulfonyl chloride |
| pentafluorobenzenesulfonylchloride |
| 2,3,4,5,6-pentafluorobenzenesulfonyl choride |
| mfcd00007427 |
| CS-D1223 |
| benzenesulfonyl chloride, 2,3,4,5,6-pentafluoro- |
| BBL104401 |
| EN300-112633 |
| PS-10806 |
| 2,3,4,5,6-pentafluorobenzenesulphonyl chloride |
| benzenesulphonyl chloride, 2,3,4,5,6-pentafluoro- |
| pentafluoro-1-benzenesulfonyl chloride |
| SY048777 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.29) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||